Acute kidney dysfunction and the critically ill

Minerva Anestesiologica

Volumn 72, Issue 3, 2006, Pages 133-143

  Hoste, E A J ^a   Kellum, J A ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Acute kidney dysfunction; Acute renal failure; Creatinine; Diuretics; Intensive care; Oliguria

Indexed keywords

ACETYLCYSTEINE; ADENOSINE RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL BLOCKING AGENT; CONTRAST MEDIUM; CREATININE; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; ERYTHROPOIETIN; GROWTH FACTOR; HYPERTENSIVE AGENT; INOTROPIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; OSTEOGENIC PROTEIN 1; SCATTER FACTOR; SOMATOMEDIN; UREMIC TOXIN; VASCULOTROPIN;

ACUTE KIDNEY FAILURE; ANEMIA; ARTICLE; BIOCOMPATIBILITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DIALYSIS MEMBRANE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG MECHANISM; EARLY INTERVENTION; EPIDEMIOLOGICAL DATA; FLUID THERAPY; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HUMAN; HYPOTENSION; HYPOVOLEMIA; IMMUNE DEFICIENCY; INFECTION; INTENSIVE CARE; KIDNEY DISEASE; KIDNEY FUNCTION TEST; KIDNEY INJURY; KIDNEY PERFUSION; LUNG DISEASE; MORBIDITY; NEPHROTOXICITY; NEUROMUSCULAR DISEASE; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PATIENT MONITORING; RENAL REPLACEMENT THERAPY; RHABDOMYOLYSIS;

CRITICAL ILLNESS; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS;

EID: 33644942155     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (97)

1. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996;275:1489-94.
2. Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004;15:1597-605.
3. Thakar CV, Worley S, Arrigain S, Yared JP, Paganini EP. Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function. Kidney Int 2005;67:1112-9.
4. Hoste E, Clermont G, Kersten A et al. Clinical evaluation of the new RIFLE criteria for acute renal failure. Crit Care 2004;8:S81.
5. Kellum JA, Levin N, Bouman C, Lameire N. Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 2002;8:509-14.
6. Bellomo R, Kellum J, Ronco C. Acute renal failure: time for consensus. Intensive Care Med 2001;27: 1685-8.
7. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative Group. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-12.
8. Druml W. Prognosis of acute renal failure 1975-1995. Nephron 1996;73:8-15.
9. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-54.
10. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-49.
11. The Acute Respiratory Distress Syndrome Network: Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000;342:1301-8.
12. Chertow GM, Levy EM, Hammermeister KM, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998;104:343-8.
13. de Mendonca A, Vincent JL, Suter PM, Moreno R, Dearden NM, Antonelli M et al. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med 2000;26:915-21.
14. Vivino G, Antonelli M, Moro M, Cottini F, Conti G, Bufi M et al. Risk factors for acute renal failure in trauma patients. Intensive Care Med 1998;24:808-14.
15. Clermont G, Acker CG, Angus DC, Sirio CA, Pinsky MR, Johnson JP. Renal failure in the ICU: Comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int 2002;62:986-96.
16. Metnitz PG, Krenn CG, Steltzer H, Lang T, Ploder J, Lens K et al. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002;30:2051-8.
17. Guerin C, Girard R, Selli JM, Perdrix JP, Ayzac L. Initial versus delayed acute renal failure in the intensive care unit. A multicenter prospective epidemiological study. Rhone-Alpes Area Study Group on Acute Renal Failure. Am J Respir Crit Care Med 2000;161:872-9.
18. Liaño F, Pascual J, the Madrid Acute Renal Failure Study Group. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Kidney Int 1996;50:811-8.
19. Cole L, Bellomo R, Silvester W, Reeves JH. A Prospective, Multicenter Study of the Epidemiology, Management, and Outcome of Severe Acute Renal Failure in a "Closed" ICU System. Am J Respir Crit Care Med 2000;162:191-6.
20. Kellum JA, Angus DC. Patients are dying of acute renal failure. Crit Care Med 2002;30:2156-7.
21. Hoste EA, Lameire NH, Vanholder RC, Benoit DD, Decruyenaere JM, Colardyn FA. Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. J Am Soc Nephrol 2003;14:1022-30.
22. Hoste EA, Blot SI, Lameire NH, Vanholder RC, De Bacquer D, Colardyn FA. Effect of nosocomial bloodstream infection on the outcome of critically ill patients with acute renal failure treated with renal replacement therapy. J Am Soc Nephrol 2004;15:454-62.
23. Manns B, Doig CJ, Lee H, Dean S, Tonelli M, Johnson D et al. Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med 2003;31:449-55.
24. Hamel MB, Davis RB, Teno JM, Knaus WA, Lynn J, Harrell F Jr et al. Older age, aggressiveness of care, and survival for seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med 1999;131:721-8.
25. Malbrain ML, Chiumello D, Pelosi P, Wilmer A, Brienza N, Malcangi V et al. Prevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive Care Med 2004;30:822-9.
26. De Waele JJ, Benoit D, Hoste E, Colardyn F. A role for muscle relaxation in patients with abdominal compartment syndrome? Intensive Care Med 2003;29:332.
27. Kellum JA. What can be done about acute renal failure? Minerva Anestesiol 2004;70:181-8.
28. Hoste EA, Kellum JA. ARF in the critically ill: Impact on morbidity and mortality. Contrib Nephrol 2004;144: 1-11.
29. Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003;63:1934-43.
30. Kellum JA, Song M, Venkataraman R. Effects of hyperchloremic acidosis on arterial pressure and circulating inflammatory molecules in experimental sepsis. Chest 2004;125:243-8.
31. Bersentes TJ, Simmons DH. Effects of acute acidosis on renal hemodynamics. Am J Physiol 1967;212:633-40.
32. Marsh JD, Margolis TI, Kim D. Mechanism of diminished contractile response to catecholamines during acidosis. Am J Physiol 1988;254:H20-7.
33. Weil MH, Houle DB, Brown EB Jr, Campbell GS, Heath C. Vasopressor agents; influence of acidosis on cardiac and vascular responsiveness. Calif Med 1958;88: 437-40.
34. Kramer AA, Postler G, Salhab KF, Mendez C, Carey LC, Rabb H. Renal ischemia/ reperfusion leads to macrophage-mediated increase in pulmonary vascular permeability. Kidney Int 1999;55:2362-7.
35. Rabb H, Wang Z, Nemoto T, Yokota N, Soleimani M. Acute renal failure leads to dysregulation of lung salt and water channels. Kidney Int 2003;63:600-6.
36. Pedoto A, Caruso JE, Nandi J, Oler A, Hoffmann SP, Tassiopoulos AK et al. Acidosis stimulates nitric oxide production and lung damage in rats. Am J Respir Crit Care Med 1999;159:397-402.
37. Lipkin GW, Kendall R, Haggett P, Turney JH, Brownjohn AM. Erythropoietin in acute renal failure. Lancet 1989; 1:1029.
38. Lipkin GW, Kendall RG, Russon LJ, Turney JH, Norfolk DR, Brownjohn AM. Erythropoietin deficiency in acute renal failure. Nephrol Dial Transplant 1990;5:920-2.
39. Nagano N, Koumegawa J, Arai H, Wada M, Kusaka M. Effect of recombinant human erythropoietin on new anaemic model rats induced by gentamicin. J Pharm Pharmacol 1990;42:758-62.
40. Eknoyan G, Wacksman SJ, Glueck HI, Will JJ. Platelet function in renal failure. N Engl J Med 1969;280:677-81.
41. Weigert AL, Schafer AI. Uremic bleeding: pathogenesis and therapy. Am J Med Sci 1998;316:94-104.
42. Mitch WE. Mechanisms causing loss of muscle in acute uremia. Ren Fail 1996;18:389-94.
43. Bailey JL, Mitch WE. Metabolic acidosis as a uremic toxin. Semin Nephrol 1996;16:160-6.
44. Tegner R, Brismar T. Experimental uremic neuropathy. Part 1. Decreased nerve conduction velocity in rats. J Neurol Sci 1984;65:29-36.
45. Palmer CA. Neurologic manifestations of renal disease. Neurol Clin 2002;20:23-34.
46. Liaño F, Junco E, Pascual J et al. The spectrum of acute renal failure in the intensive care unit compared to that seen in other settings. Kidney Int 1998;53 Suppl 66:S16-24.
47. Thakar CV, Yared JP, Worley S, Cotman K, Paganini EP. Renal dysfunction and serious infections after open-heart surgery. Kidney Int 2003;64:239-46.
48. DeFronzo BA, Beckles AD. Glucose intolerance following chronic metabolic acidosis in man. Am J Physiol 1979;236:E328-34.
49. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997;63:356-61.
50. Weekers F, Giulietti AP, Michalaki M, Coopmans W, Van Herck E, Mathieu C et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology 2003;144:5329-38.
51. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M et al. Intensive Insulin Therapy in Critically Ill Patients. N Engl J Med 2001;345:1359-67.
52. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003; 290:2041-7.
53. Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med 2004;164: 2005-11.
54. Brandstrup B, Tonnesen H, Beier-Holgersen R, Hjortso E, Ording H, Lindorff-Larsen K et al. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg 2003;238:641-8.
55. Lameire N, Hoste E. Reflections on the definition, classification, and diagnostic evaluation of acute renal failure. Curr Opin Crit Care 2004;10:468-75.
56. Moran SM, Myers BD. Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int 1985;27:928-37.
57. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
58. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130: 461-70.
59. Hoste EA, Damen J, Vanholder RC, Lameire NH, Delanghe JR, Van den Hauwe K et al. Assessment of renal function in recently admitted critically ill patients with normal serum creatinine. Nephrol Dial Transplant 2005;20:747-53. Epub 2005 Feb 8.
60. Wilson RF, Soullier G. The validity of two-hour creatinine clearance studies in critically ill patients. Crit Care Med 1980;8:281-4.
61. Sladen RN, Endo E, Harrison T. Two-hour versus 22-hour creatinine clearance in critically ill patients. Anesthesiology 1987;67:1013-6.
62. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002;40: 221-6.
63. Balik M, Jabor A, Waldauf P, Kolar M, Pavlisova M, Brest'an D et al. Cystatin C as a marker of residual renal function during continuous hemodiafiltration. Kidney Blood Press Res 2005;28:14-9.
64. Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb A. Cystatin C as a marker of GFR - history, indications, and future research. Clin Biochem 2005;38:1-8.
65. Herget-Rosenthal S, Marggraf G, Husing J, Goring F, Pietruck F, Janssen O et al. Early detection of acute renal failure by serum cystatin C. Kidney Int 2004;66:1115-22.
66. Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int 2002;62:2223-9.
67. Uchino S, Doig GS, Bellomo R, Morimatsu H, Morgera S, Schetz M et al. Diuretics and mortality in acute renal failure. Crit Care Med 2004;32:1669-77.
68. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-20.
69. Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002;162: 329-36.
70. Better OS, Rubinstein I. Management of shock and acute renal failure in casualties suffering from the crush syndrome. Ren Fail 1997;19:647-53.
71. Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol 2000;11:1553-61.
72. Marik PB. Renal dose norepinephrine. Chest 2004;126: 335-7.
73. Albanese J, Leone M, Garnier F, Bourgoin A, Antonini F, Martin C. Renal effects of norepinephrine in septic and nonseptic patients. Chest 2004;126:534-9.
74. Bellomo R, Kellum JA, Wisniewski SR, Pinsky MR et al. Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am J Respir Crit Care Med 1999;159:1186-92.
75. Birck R, Krzossok S, Markowetz F, Schnulle P, van der Woude FJ, Braun C. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 2003;362: 598-603.
76. Kellum JA. A drug to prevent renal failure? Lancet 2003;362:589-90.
77. Hoffmann U, Fischereder M, Kruger B, Drobnik W, Kramer BK. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 2004;15: 407-10.
78. Ix JH, McCulloch GE, Chertow GM. Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis. Nephrol Dial Transplant 2004;19:2747-53. Epub 2004 Aug 24.
79. Vesely DL. Natriuretic peptides and acute renal failure. Am J Physiol Renal Physiol 2003;285:F167-77.
80. Sward K, Valsson F, Odencrants P, Samuelsson O, Ricksten SE. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med 2004;32:1310-5.
81. Solez K, Morel-Maroger L, Sraer JD. The morphology of "acute tubular necrosis" in man: analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine (Baltimore) 1979;58:362-76.
82. Gettings LG, Reynolds HN, Scalea T. Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs late. Intensive Care Med 1999;25:805-13.
83. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P et al. Effect of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000;356:26-30.
84. Phu NH, Hien TT, Mai NT, Chau TT, Chuong LV, Loc PP et al. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med 2002;347:895-902.
85. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346:305-10.
86. Hakim RM, Held PJ, Stannard DC, Wolfe RA, Port FK, Daugirdas JT et al. Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int 1996;50:566-70.
87. Bloembergen WE, Hakim RM, Stannard DC, Held PJ, Wolfe RA, Agodoa LY et al. Relationship of dialysis membrane and cause-specific mortality. Am J Kidney Dis 1999;33:1-10.
88. Subramanian S, Venkataraman R, Kellum JA. Influence of dialysis membranes on outcomes in acute renal failure: a meta-analysis. Kidney Int 2002;62:1819-23.
89. Mehta RL, McDonald B, Gabbai FB, Pahl M, Pascual MT, Farkas A et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001;60:1154-63.
90. Tonelli M, Manns B, Feller-Kopman D. Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 2002;40:875-85.
91. Kellum JA, Angus DC, Johnson JP, Leblanc M, Griffin M, Ramakrishnan N et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 2002;28:29-37.
92. Van Biesen W, Vanholder R, Lameire N. Dialysis strategies in critically ill acute renal failure patients. Curr Opin Crit Care 2003;9:491-5.
93. Venkataraman R, Kellum JA. Novel approaches to the treatment of acute renal failure. Expert Opin Investig Drugs 2003;12:1353-66.
94. Wang SN, Lapage J, Hirschberg R. Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J Am Soc Nephrol 2001;12:2392-9.
95. Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 2004;15:2115-24.
96. Westenfelder C. Unexpected renal actions of erythropoietin. Exp Nephrol 2002;10:294-8.
97. Rossert J, McClellan WM, Roger SD, Verbeelen DL. Epoetin treatment: what are the argument to expect a beneficial effect on renal disease progression? Nephrol Dial Transplant 2002;17:359-62.